Expanded screening for Fabry disease in patients with chronic kidney disease not on dialysis: a multicenter Italian experience.

导出 OA

翻译打印收藏纠错

作者： Yuri,Battaglia ^[1] ; Federica,Baciga ^[1] ; Meilad,Shakkour ^[2] ; Savio,Russo ^[2] ; Giulia,Carnicella ^[2] ; Michela,Erlati ^[3] ; Gemma,Sartori ^[3] ; Giulia,Tronconi ^[3] ; Renzo,Mignani ^[4] ; Federico,Pieruzzi ^[5] ; Paolo,Colomba ^[6] ; Laura,Scichilone ^[7] ; Michele,Andreucci ^[8] ; Concetto,Sessa ^[9] ; Giovanni,Duro ^[6]

作者单位： Department of Medicine, University of Verona, Verona, Italy.;Nephrology and Dialysis Unit, Pederzoli Hospital, Peschiera del Garda, Verona, Italy. ^[1] Department of Medicine, University of Verona, Verona, Italy. ^[2] Nephrology and Dialysis Unit, Pederzoli Hospital, Peschiera del Garda, Verona, Italy. ^[3] Nephrology, Dialysis and Transplantation, IRCCS S. Orsola Hospital, University of Bologna, Bologna, Italy. ^[4] Clinical Nephrology, School of Medicine and Surgery, University of Milano, Milan, Italy.;Nephrology and Dialysis Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy. ^[5] Institute for Biomedical Research and Innovation (IRIB), National Research Council (CNR), Palermo, Italy. ^[6] Nephrology and Dialysis Unit, St. Anna University Hospital, Ferrara, Italy. ^[7] Department of Health Sciences, "Magna Graecia" University, Catanzaro, Italy. ^[8] Nephrology Unit, Ragusa Hospital, Ragusa, Italy. ^[9]

关键词 CKD Lysosomal disorders globotriaosylceramide prevalence